All In MedTech

Device Trial Radar · NCT06546046

Analysis of the Efficacy and Stability of a Wearable ECG Monitor

Analysis of the Efficacy and Stability of a Single-Channel Patch-Type Wearable Electrocardiogram Monitor

Last checked: Nov 20, 2026Latest source record: Aug 14, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

Sep 9, 2024

Primary completion

Dec 30, 2024

Study completion Mar 30, 2025

Sponsor

Lead sponsor
Mezoo Co., Ltd.Academic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 9, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Screening
FDA-regulated device
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring

Conditions

  • Arrhythmias, Cardiac
  • Bradycardia
  • Tachycardia
  • Atrial Fibrillation
  • Atrial Flutter
  • Ventricular Premature Complexes

Interventions

  • ECG monitoring by telemetry device and patch-type ECG monitor at the same timeDevice

    The patient undergoes electrocardiogram monitoring simultaneously through a telemetry device and a patch-type electrocardiograph.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The number of total QRS complexTime frame: Within 3 months after electrocardiogram monitoring procedure
  2. The rate of signal lossTime frame: Within 3 months after electrocardiogram monitoring procedure

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.